Previous close | 255.60 |
Open | 255.20 |
Bid | 256.05 x 20000 |
Ask | 256.45 x 9000 |
Day's range | 252.45 - 256.10 |
52-week range | 196.60 - 306.00 |
Volume | |
Avg. volume | 579 |
Market cap | 137.988B |
Beta (5Y monthly) | 0.60 |
PE ratio (TTM) | 21.83 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 8.29 (3.24%) |
Ex-dividend date | 16 May 2024 |
1y target est | N/A |
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
In the most recent trading session, Amgen (AMGN) closed at $271.48, indicating a +0.95% shift from the previous trading day.
In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETFs in 2024. Biotechnology is a challenging field, not ideal for […]